Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
EU clears Roche’s Polivy for certain lymphomas
The European Commission has approved Roche’s Polivy (polatuzumab vedotin) for people with previously treated aggressive lymphoma.
Heart failure market could surpass ‘$22bn by 2028’
A new report from GlobalData has estimated that the global heart failure (HF) market is expected to grow from $3.
FDA warns of surgical gowns that may not be sterile
Certain surgical gowns and surgical packs made by Cardinal Health may not be sterile and should not be used, the U.
Chinese scientists identify mosquito protein related to virus transmission
BEIJING, Jan.
China counts sharp rise in coronavirus cases, 2 in Beijing
China reported Monday a sharp rise in the number of people infected with a new coronavirus, including the first cases in the capital.
Judge slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million
(Reuters) - A Pennsylvania judge on Friday slashed to $6.
Celltrion to build plant in China
SEOUL, Jan.
This AI can detect low blood sugar from ECG readings
A team of researchers from the University of Warwick have built an artificial intelligence they say can detect hyoglycaemic events — drops in blood sugar that can pose a real threat to those with or...
VALTOCO is approved by FDA
SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc.
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
SHANGHAI and LEVERKUSEN, Germany, January 16, 2020 –WuXi Biologics (“WuXi Bio”) (2269.
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi
FRANKFURT (Reuters) - Germany’s drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence of benefits, in a setback to...
Nektar withdraws application for opioid painkiller after FDA panel's vote
(Reuters) - Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.
368
369
370
371
372
373
374
375
376
